|
Dr. Head has been instrumental in
the development of several of our new chemotherapy and
immunotherapy programs. Dr. Head and Dr. Elliott are
the co-developers and patent holders of one of the first
patented autologous breast cancer vaccines in the United
States. His major goal is to implement translational
research - the movement of laboratory-developed technologies
into the clinical setting. This is the taking
of new therapies from cell culture to an accepted therapy
for cancer patients.
As a tumor cell biologist, Dr. Head's
specialties include:
• Cell culture research
• Animal research
• Human clinical research
• Innovative chemotherapies
• Immunotherapy/cancer vaccines
• Oncogene and antisense research
• Tumor markers
Dr. Head is an Adjunct Associate Professor of Biochemistry
at Tulane University, an Adjunct Professor of Physical
and Biological Sciences at Delta State University, and
an active member of the American Association for Cancer
Research and the American Society of Clinical Oncology.
Although patients rarely meet Dr. Head, many of the
new treatments we offer are the result of his work.
|
